.png){kind=icon}
返回
Smoking Cessation, Version 3.2022
.png){kind=icon}
OA
AI
DOI：10.6004/jnccn.2023.0013.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interven-tions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, rec-ommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all pa-tients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-up with retreatment as needed. J Natl Compr Canc Netw 2023;21(3):297-322 doi: 10.6004/jnccn.2023.0013
Keyword:
CELL LUNG-CANCER
BRAF
期刊
J
IF:
16.4
论文数:
2.8K
被引数:
1.5W
机构
查看更多机构
.png){kind=icon}
